High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Items 801–865 of 865
Sinlapamongkolkul, P., Surapolchai, P., & Viprakasit, V. (2020) · Authorea · doi:10.22541/au.159363349.96608174
(2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387819-9.00029-3
Iron Deficiency in Critically III Patients: Highlighting the Role of Hepcidin
Heming, N., Montravers, P., & Lasocki, S. (2011) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-642-18081-1_7
Alfaro-Magallanes, V. M. (2022) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.71841
TGF beta Superfamily Cytokine MIC-1/GDF15 in Health and Inflammatory Diseases
Breit, S. N., & Brown, D. A. (2016) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_54-2
Öneç, B., Kös, D. M., Altun, G., & Sungur, M. A. (2023) · Konuralp Tıp Dergisi · doi:10.18521/ktd.1321364
Alkafaji, S. L., & Alalsaidissa, J. N. J. (2019) · Iraqi Journal of Cancer and Medical Genetics · doi:10.29409/ijcmg.v12i1.303
Sulaiman, S. M., & Ahmed, A. A. (2024) · Iraqi Journal of Hematology · doi:10.4103/ijh.ijh_94_23 · Cited by 1
Al-Khateeb, S. M. J., Salman, A. F., Ali, E. A., JEDDA, W. A. A., & Alwan, A. (2024) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v6i2.688 · Cited by 1
Key data from the 2024 European Thyroid Association annual meeting: “Thyroid and pregnancy”
Caron, P. J. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.101681
The Fight for Iron: A Central Theme in Host-Pathogen Interactions
Hamad, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_11 · Cited by 1
Thalassemias in Manipur, India
Singh, I. A., & Vengala, S. (2025) · Journal of Hematology and Allied Sciences · doi:10.25259/jhas_64_2024
Lyu, G., Lyu, D., Hu, Y., & Wang, W. (2025) · Journal of Fish Biology · doi:10.1111/jfb.70254
Acquired sideroblastic anemias
Barton, J. C., Edwards, C. Q., Phatak, P. D., Britton, R. S., & Bacon, B. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777035.029
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337418
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337436
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337415
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337433
Tsuge, M., Kodera, A., Sumitomo, H., Araki, T., Yoshida, R., Yasui, K., Sato, H., Washio, Y., Washio, K., Shigehara, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21432857
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337427
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337430
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337439
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337421
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J., Melander, O., & Engström, G. (2021) · Figshare · doi:10.6084/m9.figshare.14337424
Aicua, L. L., Civeira Murillo, F., & Mateo‐Gállego, R. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Nkosi, T. M., Dlamini, S., Patel, A., & Merwe, M. J. (2025) · Advanced Journal of Biomedicine & Medicine · doi:10.18081/ajbm.2025.4.352
Pathophysiology of Beta-Thalassaemia: (Part III) [Iron Overload]
Win, N. (2025) · Myanmar Medical Journal · doi:10.64455/xmma0013
Yg, N., Yang, L., Yong, H., & Li, M. (2026) · Science Progress · doi:10.1177/00368504261426679
HYPERCOAGULABILITY AND THROMBOTIC RISK IN BETA-THALASSEMIA: CLINICAL AND LABORATORY INSIGHTS
Stoencheva, S. (2026) · MEDIS – International Journal of Medical Sciences and Research · doi:10.35120/medisij0501033s
Surcharges en fer rares d’origine génétique : caractérisation clinique, fonctionnelle, et biologique
Bardou‐Jacquet, E. (2013) · theses.fr (ABES) · doi:10.70675/99eb557fz5edcz4fdezbd26z84ca08eab5aa
Role and expression of transferrin receptor 2 in erythropoiesis
Vieillevoye, M. (2013) · theses.fr (ABES) · doi:10.70675/b220ff11z0798z4616za679zf78ff5fe6900
Etude des interactions de l'axe hepcidine - ferroportine - fer et infection mycobactérienne
Agoro, R. (2016) · theses.fr (ABES) · doi:10.70675/34df87ccza2e3z4446z83c3z60e6e140a976
Lefèbvre, T. (2016) · theses.fr (ABES) · doi:10.70675/e5dc07c0zc4ffz4428z98dbzfc451dd304d1
Étude des kinases PIMs dans l’érythropoïèse normale et pathologique
Montanari, P. (2017) · theses.fr (ABES) · doi:10.70675/ac9d0c30zb388z4210za80dza0d3ede3bd86
La valence du ligand du récepteur à la transferrine 1 (TfR1) détermine son routage intracellulaire
Marchal, M. (2019) · theses.fr (ABES) · doi:10.70675/287f4632z1a33z4f6fzae7aze178b58027f9
Etude du récepteur à la transferrine de type 2 dans l'érythropoïese.
Richard, C. (2019) · theses.fr (ABES) · doi:10.70675/c36ec54fz3a93z404cz8641z05a8f1db21d5
Caulier, A. (2020) · theses.fr (ABES) · doi:10.70675/be1fe49bz54d1z42eaz98acze40f1fd3fc55
Le rôle de l'érythroferrone dans la régulation du métabolisme du fer
Sardo, U. (2020) · theses.fr (ABES) · doi:10.70675/d03e67aczc44bz4af9z8fa1zef080668f44f
Bories, G. F. P. (2011) · theses.fr (ABES) · doi:10.70675/81757398zf42fz45dcz8424z3f14e050bfb4
Rôle de l'histone désacétylase HDAC6 au cours de l'érythropoïèse humaine
Vong, P. (2022) · theses.fr (ABES) · doi:10.70675/699e8d9bz5404z43f6zabe7zdd0f0b6c8c42
Rôle de PAR2 et des macrophages dans la régulation de l'hepcidine
Berger, M. (2024) · theses.fr (ABES) · doi:10.70675/9ccfb061z3847z4ad7za0f6z9b851cfeaea4
Unveiling GDF-15: a new frontier in combating diabetic osteoporosis
Wang, N., Gao, Y., & Bai, N. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1819289
“Research has demonstrated that GDF15 can induce iron overload by inhibiting hepcidin expression (55).”
Tissue-specific role of hepcidin in iron homeostasis and innate immunity
Zumerle, S. (2015) · theses.fr (ABES) · doi:10.70675/aa2f1a08z2318z4d7fzbc43zcc7ae99d7177
Oehadian, A., Santoso, P., Prihatni, D., Kartikasari, A., Parwati, I., Handayani, D., Handoyo, T., Sutandiyo, N., Alisjahbana, B., Menzies, D., et al. (2026) · The Clinical Respiratory Journal · doi:10.1111/crj.70195
“It has been shown that the high concentration of GDF-15 is responsible for the reduced synthesis of hepcidin [31].”
Üstün, Y., Yanık, S., Uçar, F., Üstün, A. Y., Erdal, H., Coşkun, Y., & Yüksel, İ. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04929-9
“Beyond its role as an inflammatory marker, GDF15 is also known to be released during erythroid stress—elevated GDF15 levels have been reported in conditions with hyperproliferative erythropoiesis such as thalassemia [19].”
Deruelle, P., Arcieri, F., & Martineau, R. (2026) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2026.06.002
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150
Geisendörfer, T., Steinbicker, A. U., Seitzer, K. E., Schrader, L., Tiedje, D., Schlack, K., & Bögemann, M. (2026) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2026.102683
Calabrese, C. (n.d.) · Institutional Research Information System University of Turin (University of Turin)
Fukuda, T., Tokoi, S., Nishikawa, R., Hasegawa, T., Kondo, K., Kayashima, R., Kono, K., Inami, S., Amano, H., Arikawa, T., et al. (2026) · Heart and Vessels · doi:10.1007/s00380-026-02775-z
GFRAL genetic variations and circulating GFRAL in hyperemesis gravidarum
Haack, B., Neemuchwala, Z. H., DeVera, S., MacGibbon, K., Fischer, B., Höschle, F., Fasching, P. A., HOUSHOLDER, A., Vanky, E., Friese, M. A., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117975
Boonyaniwas, N., Khongphithakskul, P., Klamchuen, S., Komvilaisak, P., Charoenkwan, P., Teeraleekuli, P., Ponlakan, M., Kadegasem, P., Khlangtan, T., Tangbubpha, N., et al. (2026) · Pediatric Blood & Cancer · doi:10.1002/1545-5017.70784
Kim, S. B., Lee, M. H., Ahn, J., Ju, S. H., Lee, D. S., Choi, S., Min, K. W., Shong, M., & Kim, H. M. (2026) · Science Advances · doi:10.1126/sciadv.aee5992
Pathogenesis and Management of Iron Overload in MDS
Hershko, C. (2011) · Springer eBooks · doi:10.1007/978-94-007-0440-4_12
“... categories: in inherited hemochromatosis syndromes where abnormal hepcidin regulation results in increased intestinal iron absorption and; in iron loading anemias such as the myelodysplastic syndrome (MDS) or the inherited hemoglobinopathies such as thalassemia major (TM) and sickle cell anemia where transfusional…”
BackgroundRôle de la chaperonne HSP 70 dans l'éythropoïèse inefficace des béta-thalassémies majeures
Arlet, J. (2013) · theses.fr (ABES) · doi:10.70675/89734247zcb01z4fc0za1d6zc7037e3be2ee
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.